You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -41,453.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -6.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 3,333.6 |
| Price / Book value | -19.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | -52.3% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 26.7% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -16.93 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -21.18 | €-0.42 | -7.6 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | n/a | -28.73 | €-0.52 | -6.5 | 0.0 | n/a | n/a | 0.0% |
| Faron Pharmaceuticals names James O'Brien as CFO Sharecast News | 29 Mar |
|---|---|
| Faron Pharmaceuticals gets positive feedback from FDA meeting Sharecast News | 22 Mar |
| Appointment of Chief Financial Officer | 29-Mar-23 14:35 |
|---|---|
| Board Change | 24-Mar-23 22:26 |
| Results of AGM | 24-Mar-23 22:20 |
| Positive FDA Feedback to Progress Bexmarilimab | 22-Mar-23 14:38 |
| Notice of Faron Pharmaceuticals Ltd’s AGM | 03-Mar-23 17:12 |